228 related articles for article (PubMed ID: 17445503)
1. Dual probe with fluorescent and magnetic properties for imaging solid tumor xenografts.
Shan L; Wang S; Sridhar R; Bhujwalla ZM; Wang PC
Mol Imaging; 2007; 6(2):85-95. PubMed ID: 17445503
[TBL] [Abstract][Full Text] [Related]
2. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C
Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715
[TBL] [Abstract][Full Text] [Related]
3. Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate.
Moon WK; Lin Y; O'Loughlin T; Tang Y; Kim DE; Weissleder R; Tung CH
Bioconjug Chem; 2003; 14(3):539-45. PubMed ID: 12757377
[TBL] [Abstract][Full Text] [Related]
4. A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice.
Chen K; Yap LP; Park R; Hui X; Wu K; Fan D; Chen X; Conti PS
Amino Acids; 2012 Apr; 42(4):1329-37. PubMed ID: 21212998
[TBL] [Abstract][Full Text] [Related]
5. A novel bimodal lipidic contrast agent for cellular labelling and tumour MRI.
Kamaly N; Kalber T; Kenny G; Bell J; Jorgensen M; Miller A
Org Biomol Chem; 2010 Jan; 8(1):201-11. PubMed ID: 20024151
[TBL] [Abstract][Full Text] [Related]
6. Fluorescent liposomes as contrast agents for in vivo optical imaging of edemas in mice.
Deissler V; Rüger R; Frank W; Fahr A; Kaiser WA; Hilger I
Small; 2008 Aug; 4(8):1240-6. PubMed ID: 18666163
[TBL] [Abstract][Full Text] [Related]
7. Peptide-based MRI contrast agent and near-infrared fluorescent probe for intratumoral legumain detection.
Chen YJ; Wu SC; Chen CY; Tzou SC; Cheng TL; Huang YF; Yuan SS; Wang YM
Biomaterials; 2014 Jan; 35(1):304-15. PubMed ID: 24120038
[TBL] [Abstract][Full Text] [Related]
8. A dendrimer-based nanosized contrast agent dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice.
Koyama Y; Talanov VS; Bernardo M; Hama Y; Regino CA; Brechbiel MW; Choyke PL; Kobayashi H
J Magn Reson Imaging; 2007 Apr; 25(4):866-71. PubMed ID: 17345640
[TBL] [Abstract][Full Text] [Related]
9. A tumor-targeted nanodelivery system to improve early MRI detection of cancer.
Pirollo KF; Dagata J; Wang P; Freedman M; Vladar A; Fricke S; Ileva L; Zhou Q; Chang EH
Mol Imaging; 2006; 5(1):41-52. PubMed ID: 16779969
[TBL] [Abstract][Full Text] [Related]
10. A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging.
Zhang C; Liu T; Su Y; Luo S; Zhu Y; Tan X; Fan S; Zhang L; Zhou Y; Cheng T; Shi C
Biomaterials; 2010 Sep; 31(25):6612-7. PubMed ID: 20542559
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
12. A multimodal magnetic resonance imaging nanoplatform for cancer theranostics.
Benyettou F; Lalatonne Y; Chebbi I; Di Benedetto M; Serfaty JM; Lecouvey M; Motte L
Phys Chem Chem Phys; 2011 Jun; 13(21):10020-7. PubMed ID: 21409252
[TBL] [Abstract][Full Text] [Related]
13. A transferrin-target magnetic/fluorescent dual-mode probe significantly enhances the diagnosis of non-small cell lung cancer.
Cai J; Gu B; Cao F; Liu S
Oncotarget; 2016 Jun; 7(26):40047-40059. PubMed ID: 27223075
[TBL] [Abstract][Full Text] [Related]
14. Visualizing head and neck tumors in vivo using near-infrared fluorescent transferrin conjugate.
Shan L; Hao Y; Wang S; Korotcov A; Zhang R; Wang T; Califano J; Gu X; Sridhar R; Bhujwalla ZM; Wang PC
Mol Imaging; 2008; 7(1):42-9. PubMed ID: 18384723
[TBL] [Abstract][Full Text] [Related]
15. Multilayered, core/shell nanoprobes based on magnetic ferric oxide particles and quantum dots for multimodality imaging of breast cancer tumors.
Ma Q; Nakane Y; Mori Y; Hasegawa M; Yoshioka Y; Watanabe TM; Gonda K; Ohuchi N; Jin T
Biomaterials; 2012 Nov; 33(33):8486-94. PubMed ID: 22906608
[TBL] [Abstract][Full Text] [Related]
16. Visualization of in vivo electroporation-mediated transgene expression in experimental tumors by optical and magnetic resonance imaging.
Aung W; Hasegawa S; Koshikawa-Yano M; Obata T; Ikehira H; Furukawa T; Aoki I; Saga T
Gene Ther; 2009 Jul; 16(7):830-9. PubMed ID: 19458649
[TBL] [Abstract][Full Text] [Related]
17. Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging.
Nam T; Park S; Lee SY; Park K; Choi K; Song IC; Han MH; Leary JJ; Yuk SA; Kwon IC; Kim K; Jeong SY
Bioconjug Chem; 2010 Apr; 21(4):578-82. PubMed ID: 20201550
[TBL] [Abstract][Full Text] [Related]
18. Multimodality imaging of endothelial progenitor cells with a novel multifunctional probe featuring positive magnetic resonance contrast and near-infrared fluorescence.
Ju S; Qiu Y; Li C; Teng GJ; Ni Y
Mol Imaging; 2011 Oct; 10(5):359-69. PubMed ID: 21521551
[TBL] [Abstract][Full Text] [Related]
19. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation.
Kircher MF; Mahmood U; King RS; Weissleder R; Josephson L
Cancer Res; 2003 Dec; 63(23):8122-5. PubMed ID: 14678964
[TBL] [Abstract][Full Text] [Related]
20. Dual-modality in vivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties.
Zhou J; Sun Y; Du X; Xiong L; Hu H; Li F
Biomaterials; 2010 Apr; 31(12):3287-95. PubMed ID: 20132982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
